Future Pharmaceuticals
discusses manufacturing
trends with Robert Di Scipio,
President and CEO, Aegis Analytical.
Mani Krishnan,
Director of Product
Management for Process
Systems in Millipore
Corporation’s Bioprocess
Division, discusses
the benefits of single use
technologies for the
biopharmaceutical
manufacturing.
Dr. Burckhard Wichert
of Baxter Healthcare’s Halle,
Germany facility speaks on
location’s manufacturing
services in support of
drug - development process.
BARBARA A. PALDUS, MARK SELKER and ALFY RIDDLE,
from Finesse, discuss changes in bioprocessing.
Vijay Singh, President & Founder of Panacea Solutions Inc. and Wave Biotech LLC, discusses the use of disposable technology in the pharmaceutical industry; and its future as a cost-saving, efficiency-building solution.
The success of recombinant DNA technology derived biopharmaceuticals has necessitated the construction of large manufacturing plants...
Richard Forsyth, an Associate Director with GMP quality in Merck & Co. Inc., discusses the cleaning validation process, visual residue limits and disposable technologies.
Jason J. Kamm, Managing Consultant with Tunnell Consulting, and Philippe Cini, Ph.D., Vice President of Tunnell Consulting, discuss the advantages of a proper PAT platform.
Humberto Vega, Process Engineer of Bio Sterile Validation with Merck & Co., and Timothy J. Schultz, Process Scientist of Commercialization with Merck & Co. discuss the history of disposables and how they are being applied today.
Peter Mayberry, Executive Director of the Healthcare Compliance Packaging
Council, says getting patients to take their medications properly is a main goal of the
organization. Read on for Mayberry’s insight into unit dose packaging as a whole.
The Holy Grails of biopharmaceutical production efficiency are low installation and operating costs, coupled with short startup and rapid turnaround times that result in enhanced plant flexibility, all partnered with world-class vendor quality and regulatory support.
The pharmaceutical industry faces increasing challenges from globalization,
government regulation and pressure to reduce prescription
drug costs.
Barbara A. Paldus, Mark Selker and Alfy Riddle, from Finesse, discuss changes in bioprocessing.
Single-use technologies are being used by many biopharmaceutical manufacturers to improve facility throughputs, by significantly reducing downtime between campaigns. Adoption of disposables also promotes the development of a multi-purpose plant design because of the inherent flexibility of disposable systems.